SCHOTT Pharma AG & Co. KGaA (VIE:1SXP)

Austria flag Austria · Delayed Price · Currency is EUR
14.82
-0.08 (-0.54%)
At close: Feb 27, 2026
-41.00%
Market Cap 2.23B
Revenue (ttm) 995.03M
Net Income (ttm) 149.95M
Shares Out n/a
EPS (ttm) 0.99
PE Ratio 14.85
Forward PE 15.17
Dividend 0.18 (1.21%)
Ex-Dividend Date Feb 4, 2026
Volume n/a
Average Volume n/a
Open 14.98
Previous Close 14.90
Day's Range 14.82 - 14.98
52-Week Range 13.94 - 30.10
Beta n/a
RSI 46.96
Earnings Date Feb 11, 2026

About VIE:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application... [Read more]

Industry Glass Containers
Founded 1884
Employees 4,829
Stock Exchange Vienna Stock Exchange
Ticker Symbol 1SXP
Full Company Profile

Financial Performance

In fiscal year 2025, VIE:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.

Financial Statements

News

There is no news available yet.